학술논문
S222: EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVIDES DURABLE RESPONSES IN PATIENTS WITH HIGH-RISK FOLLICULAR LYMPHOMA, REGARDLESS OF POD24 STATUS
Document Type
article
Author
Source
HemaSphere, Vol 7, p e5547136 (2023)
Subject
Language
English
ISSN
2572-9241